Search for: "The Proctor & Gamble Manufacturing Co." Results 1 - 20 of 26
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Dec 2021, 8:18 am by Cinthia Macie
The FTC issued orders under Section 6(b) of the FTC Act—administrative subpoenas seeking detailed information—to nine of the country’s largest retailers, wholesalers, and consumer goods suppliers, including Amazon, Walmart, Proctor & Gamble, and Kraft Heinz Co. [read post]
1 Jun 2020, 4:38 am by John Hochfelder
Defendants Shulton, Inc. and Proctor & Gamble Co., Inc., its corporate parent, who manufactured the talc, are the defendants who settled the claims against them before trial (for $732,500) and against whom 50% of the liability was assigned. [read post]
21 Jul 2009, 6:56 am
., GlaxoSmithKline Consumer Healthcare LLC, GlaxoSmithKline Consumer Healthcare, LP, and Block Drug Company, Inc.) supported the Plaintiffs' motion for consolidation, while the Proctor and Gamble Fixodent Defendants (The Procter & Gamble Manufacturing Co. and The Procter & Gamble Distributing LLC) opposed consolidation. [read post]
10 Oct 2012, 6:00 am by Lisa Salazar
Swiss Precision Diagnostics (SPD), a joint venture between Inverness Medical Innovations (n/k/a Alere, Inc.) and Proctor & Gamble, manufactures the CLEARBLUE® Easy™ brand. [read post]
20 Mar 2023, 8:00 am by Sean Wajert
Proctor & Gamble Co., 311 F.R.D. 29, 53 (E.D.N.Y. 2015). [read post]
9 Mar 2011, 1:59 am
In-Soo Cho, a graduate of the University of Chicago Booth School of Business with a management history with Proctor and Gamble and Yum Restaurants International, took over. [read post]
10 Feb 2015, 1:01 pm
Proctor & Gamble Manufacturing Co., 2006 WL 3626904, at *2 (E.D. [read post]
13 Jul 2009, 11:18 am
The Proctor & Gamble Paper Products Corporation, No. 07-2799 (3d Cir. [read post]
13 May 2010, 12:27 pm by Bexis
Proctor & Gamble, 2010 WL 728222 (S.D. [read post]
28 Sep 2015, 12:19 pm by Rebecca Tushnet
  The court rejected Syngenta’s argument that a manufacturer generally has no duty to control third parties who buy and use its products, absent a special relationship, and that its corn was no different from guns, cellphones, or meth precursors. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
28 May 2020, 5:29 am by Schachtman
Another vacuous response to a methodological challenge under Rule 702 is to label the challenge as “going to the weight, not the admissibility” of the challenged expert witness’s testimony. [read post]
29 Nov 2022, 4:13 am by Bernard Bell
Can an agency properly invoke the deliberative process privilege to shield internal deliberations over a sham memo requesting that another agency take action, knowing that the recipient agency will use the request to hide the real reason for its contemplated action? [read post]
18 Feb 2010, 10:34 am by Beck, et al.
” Those burdens “deter” and “discourage” manufacturers from seeking approval of “potentially beneficial” products. [read post]